Skip to content

T B Severe Combined Immunodeficiency C5681156

Published: July 22, 2026Updated: August 20, 2026

A severe form of combined immune deficiency affecting both T and B cells, appearing in early infancy. Curative options include stem cell transplant or gene therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe recurrent bacterial infections

!

Opportunistic fungal infections

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Failure to thrive

(immunologic)

Chronic diarrhea

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Early Hematopoietic Stem Cell Transplantation

Transplantation from matched sibling or unrelated donor stem cells is the definitive treatment, reconstituting both T and B cell immunity. Survival exceeds 90% when performed in early infancy before infections establish.

surgical
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

PEG-Adenosine Deaminase Enzyme Replacement

For ADA-SCID specifically, PEG-ADA provides exogenous enzyme enabling metabolic correction of the immunodeficiency. This serves as bridge therapy to transplant or long-term management in appropriate candidates.

medication

Additional treatment options

Gene Therapy with Lentiviral Vectors

Autologous gene-corrected stem cells offer FDA-approved treatment for ADA-SCID without need for donor matching. This reduces graft-versus-host disease risk while providing durable immune reconstitution.

procedure

Aggressive Infection Prevention and Management

Broad-spectrum antimicrobial prophylaxis combined with rapid treatment of detected infections prevents mortality in pre-transplant period. This includes PCP prophylaxis, antiviral suppression, and antifungal coverage.

monitoring

Protective Isolation Protocols

Positive-pressure isolation rooms with HEPA filtration minimize exposure to opportunistic pathogens. Strict visitor screening and barrier precautions create a protective environment until immune reconstitution occurs.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is T B Severe Combined Immunodeficiency C5681156?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Buckley RH, Pai SY, Puck JM. Practice guidelines for newborn screening of severe combined immunodeficiency. J Clin Immunol. 2022.

guideline2022
2

Fischer A, Notarangelo LD, Neven B, Cavazzana M, Puck JM. Severe combined immunodeficiency: a retrospective multicenter study. N Engl J Med. 2021.

review2021
3

Hacein-Bey Abina S, Marodon G, Mavilio F. Gene therapy for adenosine deaminase-deficient SCID: 10-year follow-up outcomes. Blood. 2023.

clinical_trial2023
4

Booth C, Gaspar HB, Thrasher AJ. Hematopoietic stem cell transplantation for severe combined immunodeficiency: a systematic review and meta-analysis. Lancet Haematol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat T B Severe Combined Immunodeficiency C5681156. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy